My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 325

    1.

    Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study.

    Winkler K, Konrad T, Füllert S, Friedrich I, Destani R, Baumstark MW, Krebs K, Wieland H, März W.

    Diabetes Care. 2003 Sep;26(9):2588-94.PMID: 12941723 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes.

    Lawrence JM, Reid J, Taylor GJ, Stirling C, Reckless JP.

    Diabetes Care. 2004 Jan;27(1):41-6.PMID: 14693964 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.

    Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group.

    Coron Artery Dis. 2001 Aug;12(5):413-23.PMID: 11491207 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study.

    Füllert S, Schneider F, Haak E, Rau H, Badenhoop K, Lübben G, Usadel KH, Konrad T.

    J Clin Endocrinol Metab. 2002 Dec;87(12):5503-6.PMID: 12466345 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

    Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH; QUARTET Study Group.

    Diabetes Care. 2004 Jan;27(1):141-7.PMID: 14693980 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

    Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

    Clin Ther. 2003 Apr;25(4):1074-95.PMID: 12809958 [PubMed - indexed for MEDLINE]Related articles

    8.

    Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.

    Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.

    Clin Exp Hypertens. 2001 Aug;23(6):489-500. Erratum in: Clin Exp Hypertens 2001 Nov;23(8):667. PMID: 11478431 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.

    Rosenstock J, Einhorn D, Hershon K, Glazer NB, Yu S; Pioglitazone 014 Study Group.

    Int J Clin Pract. 2002 May;56(4):251-7.PMID: 12074206 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes.

    Tan MH, Johns D, Glazer NB.

    Clin Chem. 2004 Jul;50(7):1184-8. Epub 2004 Apr 29.PMID: 15117857 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

    Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

    Clin Ther. 2004 Mar;26(3):379-89.PMID: 15110130 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

    Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

    Clin Ther. 2004 May;26(5):744-54.PMID: 15220018 [PubMed - indexed for MEDLINE]Related articles

    13.

    A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.

    Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, Tan MH, Khan MA, Perez AT, Jacober SJ; GLAI Study Investigators.

    Diabetes Care. 2005 Jul;28(7):1547-54.PMID: 15983299 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes.

    Berneis K, Rizzo M, Stettler C, Chappuis B, Braun M, Diem P, Christ ER.

    Expert Opin Pharmacother. 2008 Feb;9(3):343-9.PMID: 18220486 [PubMed - indexed for MEDLINE]Related articles

    15.

    Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus.

    Scharnagl H, Winkler K, Mantz S, Baumstark MW, Wieland H, März W.

    Exp Clin Endocrinol Diabetes. 2004 May;112(5):269-77.PMID: 15146374 [PubMed - indexed for MEDLINE]Related articles

    16.

    Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.

    Kendall DM, Rubin CJ, Mohideen P, Ledeine JM, Belder R, Gross J, Norwood P, O'Mahony M, Sall K, Sloan G, Roberts A, Fiedorek FT, DeFronzo RA.

    Diabetes Care. 2006 May;29(5):1016-23.PMID: 16644631 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    18.

    Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.

    Hirano T, Yoshino G, Kashiwazaki K, Adachi M.

    Am J Hypertens. 2001 Sep;14(9 Pt 1):908-13.PMID: 11587157 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

    Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL.

    Am J Med. 2001 Jul;111(1):10-7.PMID: 11448655 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.

    Tan MH, Johns D, Strand J, Halse J, Madsbad S, Eriksson JW, Clausen J, Konkoy CS, Herz M; GLAC Study Group.

    Diabet Med. 2004 Aug;21(8):859-66.PMID: 15270789 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity